EKSAKTA: Berkala Ilmiah Bidang MIPA
Open Access

Characterization of Hesperidin-PEG 1000 Solid Dispersion Prepared by Freeze Drying Method

1 Master of Pharmacy Program, Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia
2 Department of Pharmaceutical Manufacturing, Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia
3 Program Study of Pharmacy, Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia
Download PDF

Abstract

Hesperidin is a disaccharide-derivative bioflavonoid in BCS class II, insoluble in water but soluble in propylene glycol and polyethylene glycol, and its poor aqueous solubility may impair bioavailability, necessitating modification via solid dispersion. In this study, a hesperidin–PEG 1000 system was prepared at 1:1 and 1:6 hesperidin:PEG 1000 ratios using freeze‑drying. The systems were characterised for crystallinity, thermal behaviour, vibrational transitions, and particle morphology. PXRD patterns recorded over 2θ = 5–40° showed that both solid dispersions retained the main diffraction peaks of pure hesperidin with reduced intensities, indicating preservation of a predominantly crystalline structure. DSC thermograms revealed a hesperidin melting peak at 261.0 °C for the pure drug, which shifted to 248.6 °C and 241.0 °C for the 1:1 and 1:6 systems, respectively, without disappearance of the drug melting event. Data from FTIR and SEM further indicated only minor molecular interactions and limited morphological changes, and the characterisation results for both ratios were essentially identical. Taken together, these findings indicate that freeze‑drying hesperidin with PEG 1000 under the applied conditions did not convert hesperidin into an amorphous, molecularly dispersed solid dispersion, but yielded a predominantly crystalline, hesperidin‑dominated system with minimal PEG 1000 incorporation.

References

1
[1] Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022). Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines, 10(9).
2
[2] Kumar, S. V. P., Vishwanath, B. A., & Swapna, D. (2024). Enhancement of solubility and dissolution rate of BCS class II drugs. International Journal of Pharmaceutical Sciences Review and Research, 84(7).
3
[3] Shekaari, H., Zafarani-Moattar, M. T., Mokhtarpour, M., & Faraji, S. (2023). Solubility of hesperidin drug in aqueous biodegradable acidic choline chloride-based deep eutectic solvents. Scientific Reports, 13(1).
4
[4] Swarup, P., & Agrawal, G. P. (2024). Development of hesperidin solid dispersion for improved solubility and dissolution using mannitol and PVP K30 as carriers. Journal of Applied Pharmaceutical Research, 12(6), 192–202.
5
[5] Xie, B., Liu, Y., Li, X., Yang, P., & He, W. (2024). Solubilization techniques used for poorly water-soluble drugs. Acta Pharmaceutica Sinica B, 14(11), 4683–4716.
Downloads
Download data is not yet available.

How to Cite

1.
Characterization of Hesperidin-PEG 1000 Solid Dispersion Prepared by Freeze Drying Method. EKSAKTA [Internet]. 2026 Jul. 27 [cited 2026 Aug. 22];27(04):536-48. Available from: https://eksakta.ppj.unp.ac.id/index.php/eksakta/article/view/702